Skip to main content
. 2024 Dec 24;55(3):36. doi: 10.3892/ijmm.2024.5477

Table II.

Recent advances in quantum dots based diagnostics for tuberculosis.

First author/s, year Nanomaterials Detection assays Target LOD Detection time (Refs.)
Hu et al, 2023 CdTe:Zn2+ QD-NB Colorimetric assays MTB DNA 2 copies/μl 55 min (61)
He et al, 2022 CdTe QD/CoTCPP Fluorescence quenching Methyl nicotinate 0.59 μM 4 min (62)
Hu et al, 2022 Double CdTe QDs/nanoCoTPyP Fluorescence quenching rpoB531/katG315 24/20 pM 95 min (63)
Kabwe et al, 2022 MA-CdSe/ZnS QDs Visual paper-based lateral flow Anti-MA antibodies NA NA (64)
Shi et al, 2024 CdTe QD/carbon dots Fluorescence quantification strategy IFN-γ/IP-10 0.3/0.5 ag/ml 8 h (65)
Kabwe et al, 2022 MA-GQDs Lateral flow tests Anti-MA antibodies NA NA (66)
Liang et al, 2021 CdTe QDs/Cu-TCPP FRET IS6110 35 pM 50 min (67)

LOD, limit of detection; MTB, Mycobacterium tuberculosis; QD-NB, quantum dot-based nanobeacon; NA, not available; CoTCPP, cobalt-metalized tetrakis(4-carboxyphenyl) porphyrin; nanoCoTPyP, nanocobalt 5,10,15,20-tetra(4-pyridyl)-21H,23H porphine; Mas, mycolic acids; GQDs, graphene quantum dots; FRET, fluorescence resonance energy transfer; TCPP, Tetrakis(4-carboxyphenyl)porphyrin; IP-10, IFN-γ-induced protein 10.